Wilson's disease;Wilsonova choroba

Casopis Lekaru Ceskych

Volumn 148, Issue 11, 2009, Pages 544-548

  Bruha R ^a,b   Marecek Z ^a   Martasek P ^a   Nevsimalova S ^a   Petrtyl J ^a   Urbanek P ^a   Kalistova H ^a   Pospisilova L ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Copper metabolism; Extrapyramidal syndrome; Liver cirrhosis; Penicillamine; Wilson's disease; Zinc

Indexed keywords

ARTICLE; GENETICS; HUMAN; PROGNOSIS; WILSON DISEASE;

HEPATOLENTICULAR DEGENERATION; HUMANS; PROGNOSIS;

EID: 70450200713     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Lancet 1912; 1:1115-1119.
2. Culota VC, Gitlin JD. Disorders of copper transport. In: Scriver CS. TheMolecular and Metabolic Basis of Inherited Disease. New York: McGraw-Hill 2001 ; 3105-3126.
3. Hellman N, Gitlin JD. Ceruloplasmin metabolism and function. Ann Rev Nutr 2002; 22: 439-458.
4. Klomp AE, Tops BB, van Denberg IE, Berger R, Klomp LW. Biochemical characterisation and subcellular localization of human copper transporter 1 (hCTR1). Biochem J 2002; 364: 497-505. (Pubitemid 34620810)
5. Kelley EJ, Palmiter RJ. A murine model of Menkes disease reveals a physiological function of metallothionein. Nat Genet 1996; 13:219-222.
6. Rae T, Schmidt P, Pufahl R, Culotta VC, O'Halloran TV. Undetectable intracellular free copper: The requirement of a copper chaperone for superoxide dismutase. Science 1999; 284: 805-808. (Pubitemid 29291346)
7. Schaefer M, Hopkins R, Failla M, Gitlin JD. Hepatocyte-specific localisation and copper-dependent trafficking of the Wilson's disease protein in the liver. Am J Physiol 1999; 276: G639-G646.
8. Tanzi RE, Petrukhin K, Chernov I, Pellequer UL, Wasco W, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993; 5: 344-350. (Pubitemid 23351304)
9. Bull Al, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to Menkes gene. Nat Genet 1993; 5: 327-337. (Pubitemid 23351302)
10. Stapelbroek JM, Bollen CW, Ploos van Amstel JK, Erpecum KJ, et al. The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis. J Hepatol 2004; 41: 758-763.
11. Mareček Z. Wilsonova choroba. Praha: Galén 1996; 143 s.
12. SchiefermeierM,KolleggerH,MadlC,PolliC,OderW,etal. TheimpactofapolipoproteinEgenotypesonageatonsetofsymptomandphenotypicexpressi oninWilson'sdisease.Brain2000;123:585-590.(Pubitemid30099542)
13. JandaJ,KotalováR,NevoralJ,ŠulákováT, SmíšekP.Akutníhemolytickákrizeseselhá nímjaterjakoprvnímanifestacemorbusWilsonudětí. ČsPediat1996;51:509-514.(Pubitemid126511788)
14. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hematology 2003; 37: 1475-1492.
15. Vrábelová S, Váňová P, Kopečková L.Trunečka P, Šmolka V, et al. Molekulární analýza Wilsonovy choroby. Čas Lék čes 2002;141:642-645.
16. Vrábelová S, Letocha O, Borský M, Kozák L. Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease. Mol Genet Metab 2005; 86: 277-285. (Pubitemid 41412185)
17. Gojová L, Jansová E, Külm M, Pouchlá S, Kozák L. Genotyping microarray as a novel approach for the detection of ATP7B gene mutations in patients with Wilson disease. Clin Genet 2008; 73: 441-452.
18. FerenciP,CacaK,LoudianosG,etal. DiagnosisandphenotypicclassificationofWilsondisease.Liver2003;23:139-142. (Pubitemid37265785)
19. Wiggelinkhuizen M, Tilanus MEC, Bollen CW, Houwen RHJ. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 2009; 29: 947-958.
20. Petrášek J, Jirsa M, Sped J, Kozák L.Taimr P, Špičák J, Filip K, Trunečka P. Revisited Kings's College score for liver transplantation in adult patients with Wilson's disease. Liver Transpl 2007;13:55-61. (Pubitemid 46099974)
21. Geissler I, Heinemann K, Rohm S, et al. Liver transplantation for hepatic and neurological Wilson's disease. Transplant Proc 2003; 35: 1445-1446. (Pubitemid 36765558)
22. Wiggelinkhuizen M.Tilanus MEC, Bollen CW, Houwen RHJ. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 2009; 29: 947-958.
23. Hoogenraad TU. Zinc treatment of Wilson's disease. J Lab Clin Med 1998; 132: 240-241.
24. Brewer GJ, Dick RD, JohnsonVD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV Long-term follow-up studies. J Lab Clin Med 1998; 132: 264-278.
25. Huster D, Leonhardt K, Mossner J. Wilson disease - update on pathophysiology and management. Ces a Slov Gastroent a Hepatol 2008; 62: 220-228.
26. Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 2007; 56:115-120. (Pubitemid 46044897)